
Ktaz P 4000mg/500mg Injection
Marketer
Healthkey Lifescience Pvt. Ltd.
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Ktaz P 4000mg/500mg Injection
Combiflox 4000mg/500mg Injection, a dual-antibiotic formulation, combats diverse bacterial infections by eliminating microorganisms. Administered solely by medical professionals, its dosage and frequency are determined by a physician based on individual health status. Strict adherence to prescribed usage is crucial. Potential side effects, including nausea, vomiting, diarrhea, and skin rashes, may occur. Injection site reactions such as pain, swelling, or redness are also possible. Persistent or worsening side effects warrant immediate medical consultation. Prior to treatment, disclose any antibiotic allergies, liver, or kidney issues to your doctor; dosage adjustments or alternative medications may be necessary. Under medical guidance, this injection is generally deemed safe during pregnancy and breastfeeding.
Uses of Ktaz P 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Ktaz P 4000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ktaz P 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Ktaz P 4000mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Ktaz P 4000mg/500mg Injection works:
Ktaz P Injection (4000mg/500mg) unites Piperacillin, a bacterial cell wall synthesis inhibitor, with Tazobactam, a beta-lactamase inhibitor. This synergistic action disables bacterial defenses, bolstering Piperacillin's antibiotic effect and overcoming bacterial resistance mechanisms.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Ktaz P 4000mg/500mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectible medication, Ktaz P 4000mg/500mg, is typically deemed safe for pregnant individuals. Preclinical trials using animal models revealed minimal or no negative consequences for fetal development; nonetheless, clinical data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Ktaz P 4000mg/500mg Injection is considered safe for breastfeeding individuals. Research in humans indicates minimal drug transfer into breast milk, posing no appreciable risk to the infant.
DrivingCONSULT YOUR DOCTOR
The impact of Ktaz P 4000mg/500mg Injection on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should use the 4000mg/500mg Ktaz P Injection cautiously. Dosage modification for this injection may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Ktaz P 4000mg/500mg Injection in patients with liver impairment appears to present a low risk. Preliminary findings indicate dose modification might be unnecessary; however, physician consultation is advised.
What if you forget to take Ktaz P 4000mg/500mg Injection :
Omit a scheduled dose of Ktaz P 4000mg/500mg Injection? Seek advice from your physician immediately.
Facts to Know About Ktaz P 4000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
